搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Caulobacter crescentus DNA ligase (ligA), partial CSB-YP858899DQO
CSB-EP858899DQO
CSB-BP858899DQO
CSB-MP858899DQO
CSB-EP858899DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP858900DQO
CSB-EP858900DQO
CSB-BP858900DQO
CSB-MP858900DQO
CSB-EP858900DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus N utilization substance protein B homolog (nusB) CSB-YP858901DQO
CSB-EP858901DQO
CSB-BP858901DQO
CSB-MP858901DQO
CSB-EP858901DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Valine--tRNA ligase (valS), partial CSB-YP858902DQO
CSB-EP858902DQO
CSB-BP858902DQO
CSB-MP858902DQO
CSB-EP858902DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus 30S ribosomal protein S5 (rpsE) CSB-YP858903DQO
CSB-EP858903DQO
CSB-BP858903DQO
CSB-MP858903DQO
CSB-EP858903DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus 50S ribosomal protein L29 (rpmC) CSB-YP858904DQO
CSB-EP858904DQO
CSB-BP858904DQO
CSB-MP858904DQO
CSB-EP858904DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus 50S ribosomal protein L4 (rplD) CSB-YP858905DQO
CSB-EP858905DQO
CSB-BP858905DQO
CSB-MP858905DQO
CSB-EP858905DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Haloalkane dehalogenase (dhmA) CSB-YP858906DQO
CSB-EP858906DQO
CSB-BP858906DQO
CSB-MP858906DQO
CSB-EP858906DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP858907DQO
CSB-EP858907DQO
CSB-BP858907DQO
CSB-MP858907DQO
CSB-EP858907DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Lipoprotein-releasing system ATP-binding protein LolD 1 (lolD1) CSB-YP858908DQO
CSB-EP858908DQO
CSB-BP858908DQO
CSB-MP858908DQO
CSB-EP858908DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus 3-demethylubiquinone-9 3-methyltransferase (ubiG) CSB-YP858909DQO
CSB-EP858909DQO
CSB-BP858909DQO
CSB-MP858909DQO
CSB-EP858909DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Isoleucine--tRNA ligase (ileS), partial CSB-YP858910DQO
CSB-EP858910DQO
CSB-BP858910DQO
CSB-MP858910DQO
CSB-EP858910DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus N-succinylarginine dihydrolase 1 (astB1) CSB-YP858911DQO
CSB-EP858911DQO
CSB-BP858911DQO
CSB-MP858911DQO
CSB-EP858911DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP858912DQO1
CSB-EP858912DQO1
CSB-BP858912DQO1
CSB-MP858912DQO1
CSB-EP858912DQO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA), partial CSB-YP858913DQO1
CSB-EP858913DQO1
CSB-BP858913DQO1
CSB-MP858913DQO1
CSB-EP858913DQO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Methionyl-tRNA formyltransferase (fmt) CSB-YP858914DQO
CSB-EP858914DQO
CSB-BP858914DQO
CSB-MP858914DQO
CSB-EP858914DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Adenosylhomocysteinase (ahcY) CSB-YP858915DQO
CSB-EP858915DQO
CSB-BP858915DQO
CSB-MP858915DQO
CSB-EP858915DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus UPF0102 protein CC_0143 (CC_0143) CSB-YP858916DQO
CSB-EP858916DQO
CSB-BP858916DQO
CSB-MP858916DQO
CSB-EP858916DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus UPF0434 protein CC_0108 (CC_0108) CSB-YP858917DQO
CSB-EP858917DQO
CSB-BP858917DQO
CSB-MP858917DQO
CSB-EP858917DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Putative NADH dehydrogenase/NAD (P)H nitroreductase CC_0061 (CC_0061) CSB-YP858918DQO
CSB-EP858918DQO
CSB-BP858918DQO
CSB-MP858918DQO
CSB-EP858918DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>